Vol 52, No 4 (2021)

Date published: 2021-08-31

Table of Contents

open access

EDITORIAL

Scientific life is changing: virtual and real-world experience

Jan Styczyński

Editorial

DOI: 10.5603/AHP.2021.0042
Acta Haematol Pol 2021;52(4):215-216.
REVIEW ARTICLE

Hematopoietic stem cell transplantation in autoimmune diseases: update from EBMT Autoimmune Diseases Working Party with special reference to Poland

John A. Snowden, Jan Styczyński, Emilian Snarski, Raffaella Greco, for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP)

Review article

DOI: 10.5603/AHP.2021.0043
Acta Haematol Pol 2021;52(4):217-224.

Autologous stem cell transplantation in lymphomas: current indications

Piotr Rzepecki

Review article

DOI: 10.5603/AHP.2021.0044
Acta Haematol Pol 2021;52(4):225-233.

Autologous hematopoietic stem cell transplantation (auto-HSCT) in children in Poland: 2021 indications and practice

Katarzyna Drabko

Review article

DOI: 10.5603/AHP.2021.0045
Acta Haematol Pol 2021;52(4):234-236.

Optimal timing and conditioning regimen in allogeneic stem cell transplantation for AML

Christoph Schmid

Review article

DOI: 10.5603/AHP.2021.0046
Acta Haematol Pol 2021;52(4):237-241.

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia

Kazimierz Hałaburda

Review article

DOI: 10.5603/AHP.2021.0048
Acta Haematol Pol 2021;52(4):245-252.

Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria in the era of complement inhibition

Mirosław Markiewicz

Review article

DOI: 10.5603/AHP.2021.0049
Acta Haematol Pol 2021;52(4):253-256.

Autoimmune cytopenias complicating hematopoietic cell transplantation

Jan Styczyński, Katarzyna Gągola, Agata Marjańska

Review article

DOI: 10.5603/AHP.2021.0050
Acta Haematol Pol 2021;52(4):257-262.

Implementation of CAR-T technology into clinical practice: challenge for cell bank

Ewa Bembnista

Review article

DOI: 10.5603/AHP.2021.0051
Acta Haematol Pol 2021;52(4):263-267.

Leukemic stem cells: clone wars

Wiesław Wiktor Jędrzejczak

Review article

DOI: 10.5603/AHP.2021.0052
Acta Haematol Pol 2021;52(4):268-271.

Myeloid/lymphoid neoplasms with eosinophilia: clinical picture and therapeutic approaches

Grzegorz Helbig

Review article

DOI: 10.5603/AHP.2021.0053
Acta Haematol Pol 2021;52(4):272-277.

Therapy of Philadelphia-negative myeloproliferative neoplasms in the blast phase

Joanna Góra-Tybor

Review article

DOI: 10.5603/AHP.2021.0054
Acta Haematol Pol 2021;52(4):278-283.

Calreticulin, a multi-faceted protein: thrombotic and bleeding risks in CALR mutation positive essential thrombocythemiaa

Krzysztof Lewandowski

Review article

DOI: 10.5603/AHP.2021.0055
Acta Haematol Pol 2021;52(4):284-290.

Old and new targets for immunotherapy of B cell acute lymphoblastic leukemia

Małgorzata Firczuk

Review article

DOI: 10.5603/AHP.2021.0056
Acta Haematol Pol 2021;52(4):291-299.

Genomic studies of Hodgkin lymphoma using circulating cell-free DNA

Iwona Wlodarska, Lieselot Buedts, Peter Vandenberghe

Review article

DOI: 10.5603/AHP.2021.0057
Acta Haematol Pol 2021;52(4):300-304.

Hodgkin lymphoma: differences and differential diagnosis

Andrzej Gruchała

Review article

DOI: 10.5603/AHP.2021.0058
Acta Haematol Pol 2021;52(4):305-308.

Treatment of Hodgkin lymphoma relapse after autologous hematopoietic cell transplantation

Justyna Rybka, Tomasz Wróbel

Review article

DOI: 10.5603/AHP.2021.0059
Acta Haematol Pol 2021;52(4):309-313.

Management of nodular lymphocyte-predominant Hodgkin lymphoma: recommendations and unresolved dilemmas

Ewa Paszkiewicz-Kozik

Review article

DOI: 10.5603/AHP.2021.0060
Acta Haematol Pol 2021;52(4):314-319.

Improving first-line treatment in diffuse large B-cell lymphoma

Monika Palka, Wojciech Jurczak

Review article

DOI: 10.5603/AHP.2021.0061
Acta Haematol Pol 2021;52(4):320-324.

Dose adjusted R-EPOCH and other etoposide-containing regimens in first-line treatment of diffuse large B-cell lymphoma

Igor Aurer

Review article

DOI: 10.5603/AHP.2021.0062
Acta Haematol Pol 2021;52(4):325-328.

Novel monoclonal antibodies for diffuse large B-cell lymphoma

Jan Walewski

Review article

DOI: 10.5603/AHP.2021.0063
Acta Haematol Pol 2021;52(4):329-333.

Treatment of peripheral T-cell lymphomas

Grzegorz Mazur, Justyna Kanclerska

Review article

DOI: 10.5603/AHP.2021.0064
Acta Haematol Pol 2021;52(4):334-339.

Primary central nervous system lymphoma: how to treat younger patients

Beata Ostrowska

Review article

DOI: 10.5603/AHP.2021.0065
Acta Haematol Pol 2021;52(4):340-344.

Role of targeted therapy in central nervous system lymphoma

Róża Kot, Monika Długosz-Danecka

Review article

DOI: 10.5603/AHP.2021.0066
Acta Haematol Pol 2021;52(4):345-348.

Primary central nervous system lymphoma in neurosurgery

Dariusz Szczepanek, Filip Stoma, Aleksandra Szczepanek

Review article

DOI: 10.5603/AHP.2021.0067
Acta Haematol Pol 2021;52(4):349-354.

Folliculotropic mycosis fungoides

Małgorzata Sokołowska-Wojdyło

Review article

DOI: 10.5603/AHP.2021.0068
Acta Haematol Pol 2021;52(4):355-360.

The importance of cytogenetic and molecular aberrations in multiple myeloma

Artur Jurczyszyn, Grzegorz Charliński, Anna Suska, David H. Vesole

Review article

DOI: 10.5603/AHP.2021.0069
Acta Haematol Pol 2021;52(4):361-370.

New opportunities in immunotherapy in multiple myeloma

Dominik Dytfeld

Review article

DOI: 10.5603/AHP.2021.0070
Acta Haematol Pol 2021;52(4):371-374.

Peripheral neuropathy in patients with multiple myeloma: molecular effects of bortezomib

Karolina Łuczkowska, Bogusław Machaliński

Review article

DOI: 10.5603/AHP.2021.0071
Acta Haematol Pol 2021;52(4):375-381.

Monoclonal gammopathy of clinical significance (MGCS): when monoclonal gammopathy of undetermined significance (MGUS) is no longer undetermined

Lidia Usnarska-Zubkiewicz

Review article

DOI: 10.5603/AHP.2021.0072
Acta Haematol Pol 2021;52(4):382-389.

FISH diagnostics in plasma cell myeloma: recommendations and own experience

Renata Woroniecka

Review article

DOI: 10.5603/AHP.2021.0073
Acta Haematol Pol 2021;52(4):390-396.

Anemia in cancer patients

Lukasz Bolkun, Janusz Kloczko

Review article

DOI: 10.5603/AHP.2021.0074
Acta Haematol Pol 2021;52(4):397-401.

Anemia in children: a pediatrician’s view

Michał Matysiak

Review article

DOI: 10.5603/AHP.2021.0075
Acta Haematol Pol 2021;52(4):402-405.

Methods of pathogen inactivation in whole blood and red blood cells: current state of knowledge

Elżbieta Lachert

Review article

DOI: 10.5603/AHP.2021.0076
Acta Haematol Pol 2021;52(4):406-411.

Artificial tears to treat dry eye syndrome

Jolanta Antoniewicz-Papis

Review article

DOI: 10.5603/AHP.2021.0077
Acta Haematol Pol 2021;52(4):412-415.

Anticoagulant treatment of venous thromboembolism in pregnant women

Anetta Undas

Review article

DOI: 10.5603/AHP.2021.0078
Acta Haematol Pol 2021;52(4):416-421.

Emicizumab in severe hemophilia A

Jerzy Windyga

Review article

DOI: 10.5603/AHP.2021.0079
Acta Haematol Pol 2021;52(4):422-428.

Prevention and treatment of venous thromboembolism in patients with hematological neoplasms

Joanna Rupa-Matysek

Review article

DOI: 10.5603/AHP.2021.0080
Acta Haematol Pol 2021;52(4):429-435.

Risk assessment of recurrent venous thromboembolism

Jacek Musiał

Review article

DOI: 10.5603/AHP.2021.0081
Acta Haematol Pol 2021;52(4):436-441.

Viscoelastic methods in clinical laboratory hematology: a narrative review

Joanna Boinska, Ewelina Kolańska-Dams, Artur Słomka, Ewa Żekanowska

Review article

DOI: 10.5603/AHP.2021.0082
Acta Haematol Pol 2021;52(4):442-445.
ORIGINAL RESEARCH ARTICLE

Therapeutic monitoring of direct oral anticoagulants — an 8-year observational study

Grzegorz Grześk

Original research article

DOI: 10.5603/AHP.a2021.0039
Acta Haematol Pol 2021;52(4):446-452.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl